Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 15

Results For "Head"

2418 News Found

We plan to invest nearly $100 million in new infrastructure, biologics and AI-driven drug discovery,: Akhil Ravi, CEO, Aurigene
interviews | June 16, 2026

We plan to invest nearly $100 million in new infrastructure, biologics and AI-driven drug discovery,: Akhil Ravi, CEO, Aurigene

Since 2022, we have grown threefold and our growth story is built on scale, scientific innovation and deep customer partnerships


India’s bioeconomy grew 20-fold in last 12 years: Dr Jitendra Singh
Policy | June 16, 2026

India’s bioeconomy grew 20-fold in last 12 years: Dr Jitendra Singh

From a $10 billion bioeconomy to over $190 billion, indigenous CAR-T therapy, and a booming startup ecosystem highlight 12 years of transformation in India’s science and technology landscape


Arihant Innochem launches state-of-the-art research & innovation centre in Navi Mumbai
News | June 15, 2026

Arihant Innochem launches state-of-the-art research & innovation centre in Navi Mumbai

The new facility aims to accelerate formulation science and application-led research across pharma, biopharma, nutraceuticals, personal care, and home care segments


Suven Life Sciences to showcase narcolepsy program Samelisant at SLEEP 2026
News | June 14, 2026

Suven Life Sciences to showcase narcolepsy program Samelisant at SLEEP 2026

Samelisant will be the centerpiece of Suven’s scientific presence


India clears major milestone in cervical cancer fight with validation of first indigenous HPV DNA test
News | June 14, 2026

India clears major milestone in cervical cancer fight with validation of first indigenous HPV DNA test

Cervical cancer remains one of the leading causes of cancer deaths among women in India


India validates first indigenous HPV DNA test for cervical cancer screening
Healthcare | June 13, 2026

India validates first indigenous HPV DNA test for cervical cancer screening

Molbio Diagnostics' Truenat HPV-HR Plus becomes the world's first formally validated reduced-valency HPV test, meeting WHO-IARC standards


FDA clears Wave Neuroscience’s AI-guided brain stimulation platform for PTSD treatment
Medical Device | June 13, 2026

FDA clears Wave Neuroscience’s AI-guided brain stimulation platform for PTSD treatment

MeRT becomes one of the few FDA-cleared neuromodulation therapies for PTSD, using EEG biomarkers and AI to personalize treatment for patients with treatment-resistant symptoms


Relmada Therapeutics bolsters Sepranolone Program with Michael Quirk as Senior Advisor
People | June 13, 2026

Relmada Therapeutics bolsters Sepranolone Program with Michael Quirk as Senior Advisor

Dr. Quirk said the program’s mechanism offers a targeted approach to disrupted brain signaling in compulsivity-related disorders


MedGenome documentary highlights role of genomics in personalized cancer care
News | June 12, 2026

MedGenome documentary highlights role of genomics in personalized cancer care

The film tells the story of a 70-year-old woman from Kota, Rajasthan, whose persistent cough led to a diagnosis of advanced lung cancer